Matinas BioPharma Holdings Cash Flow Statement (2013-2026) | MTNB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-4.79M	-6.88M	-6.71M	-7.72M	-5.92M	-5.46M	-5.48M	-5.59M	-6.16M	-6.13M	-5.89M	-5.90M	-5.84M	-4.38M	-8.47M	-1.95M	-1.84M	-1.58M	-1.60M	-1.94M
Depreciation and Depletion (Quarter)	0.06M	0.06M	-0.17M
Share-based Compensation (Quarter)	1.06M	1.06M	1.07M	1.26M	1.22M	1.41M	1.34M	1.27M	1.21M	1.20M	1.27M	0.99M	0.99M	0.96M	0.24M	0.32M	0.24M	0.25M	0.22M	0.11M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	9.82M	22.24M	0.01M	27.75M	27.73M	27.78M	0.01M	0.00M	34.54M	0.30M	0.00M	0.00M	46.03M	0.87M	0.00M	0.00M	0.11M	0.12M	0.01M	0.01M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)			0.00M				0.09M				0.02M
Cash from Operations (Quarter)	-0.86M	-5.75M	-3.96M	-4.76M	-5.13M	-4.97M	-4.30M	-4.09M	-2.19M	-4.42M	-4.58M	-5.77M	-3.11M	-3.50M	-3.51M	-2.01M	-2.02M	-1.47M	-1.51M	-1.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.12M	0.01M	0.13M	0.06M	0.14M	0.00M	0.13M	0.04M	0.00M	0.14M	-0.08M	0.00M	0.15M	0.15M	0.16M	0.00M	0.00M	0.00M	-0.33M	0.07M
Amortization of Deferred Charges (Quarter)	0.12M
Depreciation & Amortization (CF) (Quarter)	0.06M	0.06M	0.06M	0.07M	0.09M	0.09M	0.09M	0.09M	0.10M	0.10M	0.10M	0.09M	0.09M	0.09M	0.09M	0.02M	0.01M	-0.00M	0.00M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)	0.03M	0.21M	0.28M	0.41M	-0.85M	0.16M	-0.04M	-0.10M	0.09M	0.23M	-0.32M	-0.04M	-0.23M	0.11M	-0.25M	0.19M	-0.12M	-0.09M	0.23M	0.40M
Change in Accured Expenses (Quarter)	1.36M	0.13M	-0.04M	-1.01M	2.45M	-0.60M	-0.60M	-2.31M	0.58M	0.39M	-0.31M	-0.61M	0.60M	-0.40M	0.77M	-0.63M	-0.38M	-0.23M	-0.12M	0.24M
Other Working Capital Changes (Quarter)	1.34M	1.34M	-1.01M	0.37M	0.37M	1.14M	1.52M	-2.42M	0.04M	1.31M	-0.15M	0.68M	0.68M	0.04M	-0.11M	0.20M	0.34M	0.34M	-0.48M	0.01M
Investing Activities
Capital Expenditures (Quarter)			0.04M	0.55M	0.06M	0.25M	0.04M			0.02M
Sales of Property, Plant and Equipment (Quarter)																			0.01M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	10.70M	11.12M	5.50M	6.00M	3.25M	6.00M		3.00M	6.40M	1.10M	2.96M	2.00M	5.00M	10.14M	0.50M
Cash from Investing Activities (Quarter)	7.65M	0.24M	0.06M	2.96M	-3.79M	5.75M	-0.04M	3.00M	6.20M	1.08M	2.96M	2.00M	-2.94M	9.65M	0.50M				0.01M
Financing Activities
Other financing activities (Quarter)																0.00M	0.03M
Cash from Financing Activities (Quarter)	0.18M	-0.01M	0.01M	0.09M	-0.01M	-0.00M	-0.01M	-0.00M	-0.00M	-0.00M	-0.00M	0.05M	9.19M	-0.07M	-0.00M	1.65M	1.62M	0.06M	0.06M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Change in Cash (Quarter)	6.97M	-5.52M	-3.89M	-1.70M	-8.93M	0.78M	-4.35M	-1.09M	4.00M	-3.34M	-1.62M	-3.72M	3.15M	6.08M	-3.01M	-0.36M	-0.40M	-1.09M	-1.44M	-1.60M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)	-0.86M	-5.75M	-3.99M	-5.30M	-5.19M	-5.22M	-4.34M	-4.09M	-2.19M	-4.43M	-4.58M	-5.77M	-3.11M	-3.50M	-3.51M	-2.01M	-2.02M	-1.47M	-1.51M	-1.60M
Net Cash Flow (Quarter)	6.97M	-5.52M	-3.89M	-1.70M	-8.93M	0.78M	-4.35M	-1.09M	4.00M	-3.34M	-1.62M	-3.72M	3.15M	6.08M	-3.01M	-0.36M	-0.40M	-1.41M	-1.44M	-1.60M

Research Tools

Developers

Matinas BioPharma Holdings Cash Flow Statement (2013-2026) | MTNB

Research Tools

Developers

Matinas BioPharma Holdings Cash Flow Statement (2013-2026) | MTNB

Create an account

Sign In

Reset Password